34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McKenzie, M
  • Chi, K
  • Neville, A
  • Ellard, S
  • Baerg, B
  • Ruether, D
  • Winquist, E
  • Segal, R
  • Attwell, A
  • Lukka, Himu

publication date

  • September 2006